Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification

University of Brighton, United Kingdom.
Experimental gerontology (Impact Factor: 3.49). 07/2009; 44(10):659-65. DOI: 10.1016/j.exger.2009.07.004
Source: PubMed


Little is known about the senescent phenotype of human vascular smooth muscle cells (VSMCs) and the potential involvement of senescent VSMCs in age-related vascular disease, such as atherosclerosis. As such, VSMCs were grown and characterised in vitro to generate senescent VSMCs needed for microarray analysis (Affymetrix). Comparative analysis of the transcriptome profiles of early (14 CPD) and late (39-42 CPD) passage VSMCs found a total of 327 probesets called as differentially expressed: 149 are up-regulated in senescence and 178 repressed (p-value<0.5%, minimum effect size of at least 2-fold differential regulation, explore data at Data mining shows a differential regulation of genes at senescence associated with the development of atherosclerosis and vascular calcification. These included genes with roles in inflammation (IL1beta, IL8, ICAM1, TNFAP3, ESM1 and CCL2), tissue remodelling (VEGF, VEGFbeta, ADM and MMP14) and vascular calcification (MGP, BMP2, SPP1, OPG and DCN). The microarray data for IL1beta, IL8 and MGP were validated by either, ELISA, Western blot analysis or RT-PCR. These data thus provide the first evidence for a role of VSMC senescence in the development of vascular calcification and provides further support for the involvement of senescent VSMCs in the progression of atherosclerosis.

Download full-text


Available from: Dominick G.A Burton,
61 Reads
  • Source
    • "ismal lifespan entry into the senescent state probably prevents the growth of tumors , thus contributing to organismal survival . However , cellular senescence is typically associated with the heavily upregulated secretion of proinflammatory factors and other changes which have the potential to produce degenerative effects ( Coppé et al . , 2008 ; Burton et al . , 2009 ; Kipling et al . , 2009 ) . As a result of declining clearance rates with age senescent cells accumulate in multiple tissues with in vivo age in a variety of species ( Kipling et al . , 2004 ; Herbig et al . , 2006 ) . The best evidence that senescent cells play a causal role in aging is the recent observation that their ablation in a "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aging of the population represents one of the largest healthcare challenges facing the world today. The available scientific evidence shows that interventions are available now that can target fundamental "aging" processes or pathways. Sufficient economic evidence is available to argue convincingly that this approach will also save enormous sums of money which could then be deployed to solve other urgent global problems. However, as yet this scenario has barely entered the public consciousness and, far from being a point of vigorous debate, seems to be ignored by policy makers. Understanding why this lethargy exists is important given the urgent need to deal with the challenge represented by population aging. In this paper I hypothesize that one major cause of inaction is a widely held, but flawed, conceptual framework concerning the relationship between aging and disease that categorizes the former as "natural" and the latter as "abnormal." This perspective is sufficient in itself to act as a disincentive to intervention by rendering those who hold it prone to the "naturalistic fallacy" but can give rise to active hostility to biogerontology if coupled with loose and/or blurred understanding of the goals and potential of the field.
    Frontiers in Genetics 07/2015; 6:171. DOI:10.3389/fgene.2015.00171
  • Source
    • "Endothelial cell (EC) and vascular smooth muscle cell (VSMC) senescence in particular has been linked to the development of cardiovascular disease, specifically atherosclerosis [1-3]. The senescent phenotype has been proposed to result in an impaired ability to replace damaged or lost cells or to produce altered tissue microenvironments within the vessel [4]. Accordingly we reviewed the available data on proliferative capacity, donor age and cardiovascular disease status with regard to these cell types, in order to produce a meta-dataset spanning a range of age groups and cardiovascular disease states, allowing provisional conclusions to be drawn. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A growing body of evidence demonstrates that the accumulation of senescent cells is a plausible ageing mechanism. It has been proposed that the senescence of vascular cells plays a causal role in the development of cardiovascular pathologies. A key prediction arising from this hypothesis is that cultures of cells derived from donors with cardiovascular disease will show reduced in vitro replicative capacities compared to those derived from disease-free controls. Accordingly, we carried out a formal review of the relationship among donor age, cardiovascular health status and maximum population doubling level attained in vitro by cultures of vascular smooth muscle and endothelial cells. Data were available to us on a total of 202 independent cell cultures. An inverse relationship was found to exist between replicative capacity and donor age in both endothelial and vascular smooth muscle cells. Cultures derived from donors with cardiovascular disease showed a lower overall replicative potential than age-matched healthy controls. In general the replicative potential at the start of the lifespan was found to be higher in those individuals without disease than those with disease and the difference in average cumulative population doublings (CPDs) in age-matched individuals in the two groups remained roughly constant throughout the lifetime. These results are consistent with the model in which the inherited replicative capacity of vascular cells is a stronger determinant of the onset of cardiovascular disease later in life, than wear-and-tear throughout the life course.
    02/2013; 2(1). DOI:10.1186/2046-2395-2-3
  • Source
    • "However, we did not see in aged human mammary arteries any regulation of RunX2, a key transcription factor in osteoblast differentiation, which participates in the VSMC calcifying process (Gaur et al., 2005; Byon et al., 2008; Speer et al., 2009). Altogether, our observations are in line with recent publications showing that senescent VSMC can transdifferentiate into osteochondrogenic precursors , an early step in vascular calcification (Burton et al., 2009; Nakano-Kurimoto et al., 2009; Speer et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aging is the main risk factor for cardiovascular diseases, but the associated molecular mechanisms are poorly understood. The Wnt signaling pathway was shown to be induced during aging in muscle and in the skin, but the regulation and role of Wnt signaling in the aged vessel have not yet been addressed. While screening for age-related changes in gene expression in the intima/media of human mammary arteries, we observed that the expression of frizzled 4 (Fzd4), a Wnt receptor, and of several targets of the Wnt/β-catenin/TCF signaling pathway [Wnt-inducible secreted protein 1 (WISP1), versican, osteopontin (SPP1), insulin-like growth factor binding protein 2 (IGFBP-2), and p21] were modified with age, suggesting an activation of the Wnt/β-catenin pathway. In contrast, we did not observe any regulation of forkhead transcription factor (FoxO) target genes. Beta-catenin-activating phosphorylation at position Ser675 was increased in aging mammary arteries, confirming the activation of this pathway. We confirmed in vitro that Wnt3a or Wnt1 treatment of human vascular smooth muscle cells (VSMCs) induced β-catenin phosphorylation at Ser675 and WISP1, SPP1, and IGFBP-2 expression. In vitro, Wnt treatment induced proliferation and cyclin D1 expression in VSMC from young (6 weeks old) rats but not in cells from older rats (8 months old), even though low-density lipoprotein receptor-related protein 6 and β-catenin phosphorylation, and β-catenin nuclear translocation demonstrated β-catenin activation in both cell types. Beta-catenin silencing demonstrated that Wnt induction of cyclin D1 expression is β-catenin dependent. Altogether, our data show that the Wnt/β-catenin/TCF pathway is activated in aging human mammary artery cells, but fails to induce the proliferation of aging vascular cells.
    Aging cell 11/2010; 10(2):220-32. DOI:10.1111/j.1474-9726.2010.00661.x · 6.34 Impact Factor
Show more